Gainers

  • Twist Bioscience TWST stock increased by 14.1% to $36.51 during Thursday's after-market session. The company's market cap stands at $2.1 billion. The company's, Q2 earnings came out today.
  • Jaguar Health JAGX shares increased by 13.91% to $0.33. The company's market cap stands at $95.9 million.
  • Tandem Diabetes Care TNDM stock moved upwards by 12.25% to $41.04. The market value of their outstanding shares is at $2.6 billion. As per the press release, Q1 earnings came out today.
  • Indaptus Therapeutics INDP stock moved upwards by 11.29% to $2.26. The company's market cap stands at $19.2 million.
  • Ardelyx ARDX shares rose 11.02% to $7.54. The company's market cap stands at $1.7 billion. As per the news, the Q1 earnings report came out today.
  • NKGen Biotech NKGN shares rose 8.33% to $1.43. The market value of their outstanding shares is at $32.6 million.

Losers

  • Cue Biopharma CUE shares declined by 7.5% to $1.74 during Thursday's after-market session. The company's market cap stands at $84.6 million.
  • Cardiff Oncology CRDF stock decreased by 6.7% to $4.18. The market value of their outstanding shares is at $186.8 million. The company's, Q1 earnings came out today.
  • Orchestra BioMed Hldgs OBIO shares declined by 6.31% to $5.2. The market value of their outstanding shares is at $186.0 million.
  • Aptevo Therapeutics APVO stock declined by 6.12% to $1.06. The company's market cap stands at $3.8 million.
  • Allarity Therapeutics ALLR shares fell 5.7% to $1.16. The company's market cap stands at $2.2 million.
  • Varex Imaging VREX shares decreased by 5.67% to $15.5. The market value of their outstanding shares is at $629.5 million. The company's, Q2 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!